In our opinion, patients presenting with disproportional growth failure should be referred for genetic testing to assess the presence of PSVs in SMARCAL1 to avoid overtreatment with immunosuppressive agents in the case of SIOD. The gene discussed is SMARCAL1; the disease is Schimke immuno-osseous dysplasia.